Epidermal growth factor-related peptides and their receptors in human malignancies.

[1]  G. Murphy,et al.  UICC meeting on breast‐cancer screening in pre‐menopausal women in developed countries. Geneva, 29 September‐1 October 1993 , 2007, International journal of cancer.

[2]  N. Normanno,et al.  Identification and biological characterization of an epidermal growth factor-related protein: cripto-1. , 1994, Journal of Biological Chemistry.

[3]  G. Merlo,et al.  Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas. , 1994, British Journal of Cancer.

[4]  N. Normanno,et al.  Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H. Friess,et al.  Cripto, a member of the epidermal growth factor family, is over‐expressed in human pancreatic cancer and chronic pancreatitis , 1994, International journal of cancer.

[6]  G. Fontanini,et al.  Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides. , 1994, Oncogene.

[7]  C. Harris,et al.  p53: at the crossroads of molecular carcinogenesis and risk assessment. , 1993, Science.

[8]  N. Copeland,et al.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer , 1993, Cell.

[9]  G. Plowman,et al.  Heregulin induces tyrosine phosphorylation of HER4/p180erbB4 , 1993, Nature.

[10]  Y. Yarden,et al.  Neu and its ligands: From an oncogene to neural factors , 1993, BioEssays : news and reviews in molecular, cellular and developmental biology.

[11]  A. Knudson,et al.  Antioncogenes and human cancer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Roop,et al.  Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[13]  F. Ciardiello,et al.  Loss of thyrotropin regulation and transforming growth factor beta-induced growth arrest in erbB-2 overexpressing rat thyroid cells. , 1993, Cancer research.

[14]  J. Marx.  Two major signal pathways linked. , 1993, Science.

[15]  J. Moul,et al.  Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma. , 1993, The Journal of urology.

[16]  E. Kleinerman,et al.  Liposome-encapsulated MTP-PE: a novel biologic agent for cancer therapy. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[17]  G. Finlay,et al.  Genetics, molecular biology and colorectal cancer. , 1993, Mutation research.

[18]  E. Tubb,et al.  Growth factor mRNA expression in human head and neck malignant tumors. , 1993, Archives of otolaryngology--head & neck surgery.

[19]  R. Lupu,et al.  Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors. , 1993, Cancer research.

[20]  R. Weinberg,et al.  The pathway to signal achievement , 1993, Nature.

[21]  H. Friess,et al.  Overexpression of HER2/neu oncogene in human pancreatic carcinoma. , 1993, Human pathology.

[22]  M. Sternberg,et al.  Specific short transmembrane sequences can inhibit transformation by the mutant neu growth factor receptor in vitro and in vivo. , 1993, Oncogene.

[23]  N. Yamanaka,et al.  Relationship of C‐erbB‐2 protein expression and gene amplification to invasion and metastasis in human gastric cancer , 1993, Cancer.

[24]  I. Pastan,et al.  Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells. , 1993, Journal of neurosurgery.

[25]  L. Akslen,et al.  Prognostic impact of EGF-receptor in papillary thyroid carcinoma. , 1993, British Journal of Cancer.

[26]  J. Baselga,et al.  Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts. , 1993, Cancer research.

[27]  J. Darnell,et al.  A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. , 1993, Science.

[28]  J. Pouysségur,et al.  Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  G. Plowman,et al.  Characterization of a breast cancer cell differentiation factor that specifically activates the HER4/p180erbB4 receptor. , 1993, The Journal of biological chemistry.

[30]  W. Gullick,et al.  Characterization of high and low molecular weight forms of amphiregulin that differ in glycosylation and peptide core length. Evidence that the NH2-terminal region is not critical for bioactivity. , 1993, The Journal of biological chemistry.

[31]  N. Normanno,et al.  Expression of transforming growth factor α antisense mRNA inhibits the estrogen‐induced production of TGFα and estrogen‐induced proliferation of estrogen‐responsive human breast cancer cells , 1993 .

[32]  K. Min,et al.  Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. F. Lin,et al.  Transforming growth factor-beta 1 induces transforming growth factor-alpha promoter activity and transforming growth factor-alpha secretion in the human colon adenocarcinoma cell line FET. , 1993, Cancer research.

[34]  W. Dougall,et al.  Interaction of the neu/p185 and EGF receptor tyrosine kinases: Implications for cellular transformation and tumor therapy , 1993, Journal of cellular biochemistry.

[35]  S. Cook,et al.  RapV12 antagonizes Ras‐dependent activation of ERK1 and ERK2 by LPA and EGF in Rat‐1 fibroblasts. , 1993, The EMBO journal.

[36]  I. Kim,et al.  Urinary epidermal growth factor in patients with gliomas: significance of the factor as a glial tumor marker. , 1993, Journal of neurosurgery.

[37]  I. Pastan,et al.  Immunotoxins and recombinant toxins in the treatment of solid carcinomas. , 1993, American journal of surgery.

[38]  T. Pawson,et al.  Molecular cloning of the mouse grb2 gene: differential interaction of the Grb2 adaptor protein with epidermal growth factor and nerve growth factor receptors , 1993, Molecular and cellular biology.

[39]  A. Brunet,et al.  Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts , 1993, The Journal of cell biology.

[40]  M. Waterfield,et al.  Purification of multiple forms of glial growth factor. , 1993, The Journal of biological chemistry.

[41]  M. Klagsbrun,et al.  Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen. , 1993, The Journal of biological chemistry.

[42]  D. Haugen,et al.  Demonstration of a TGF‐α‐EGF‐receptor autocrine loop and c‐myc protein over‐expression in papillary thyroid carcinomas , 1993 .

[43]  R. Eddy,et al.  Structural organization and chromosomal assignment of the gene encoding the human heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor. , 1993, Biochemistry.

[44]  K. Haruma,et al.  Expression of Amphiregulin, a Novel Gene of the Epidermal Growth Factor Family, in Human Gastric Carcinomas , 1993, Japanese journal of cancer research : Gann.

[45]  K. M. Mulder,et al.  Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[46]  K. Fujiwara,et al.  Serum levels of transforming growth factor‐α in patients after partial hepatectomy as determined with an enzyme‐linked immunosorbent assay , 1993, Hepatology.

[47]  J. Grandis,et al.  Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. , 1993, Cancer research.

[48]  D. McCance,et al.  The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes , 1993, Journal of virology.

[49]  A. Simeone,et al.  The murine cripto gene: expression during mesoderm induction and early heart morphogenesis. , 1993, Development.

[50]  A. Harris,et al.  Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer. , 1993, Cancer research.

[51]  N. Lemoine,et al.  Expression of the c‐erbB‐3 gene product in gastric cancer , 1993, International journal of cancer.

[52]  N. Normanno,et al.  Infection with a transforming growth factor α anti‐sense retroviral expression vector reduces the in vitro growth and transformation of a human colon cancer cell line , 1993, International journal of cancer.

[53]  D. Bigner,et al.  Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. , 1993, Cancer research.

[54]  V. C. Yang,et al.  Acidic fgf and egf are involved in the autocrine growth stimulation of a human nasopharyngeal carcinoma cell line and sub‐line cells , 1993, International journal of cancer.

[55]  S. Noguchi,et al.  Down‐regulation of transforming growth factor‐α by tamoxifen in human breast cancer , 1993 .

[56]  K. Pavelić,et al.  Evidence for a role of EGF receptor in the progression of human lung carcinoma. , 1993, Anticancer research.

[57]  B. Ottesen,et al.  Expression of Epidermal Growth Factor Receptors in Human Endometrial Carcinoma , 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[58]  G. Gibson,et al.  The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival. , 1993, British Journal of Cancer.

[59]  A. Levinson,et al.  Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells. , 1993, Science.

[60]  J. Travis.  Novel anticancer agents move closer to reality. , 1993, Science.

[61]  R L Smith,et al.  Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. , 1993, Science.

[62]  M. Volm,et al.  Expression of resistance factors (P‐glycoprotein, glutathione S‐transferase‐π, and topoisomerase II) and their interrelationship to proto‐oncogene products in renal cell carcinomas , 1993, Cancer.

[63]  A. Gazdar,et al.  Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations. , 1993, Journal of the National Cancer Institute.

[64]  P. Bork,et al.  Epidermal growth factor-like modules , 1993 .

[65]  B. Stenkvist,et al.  Gene amplification detected in carcinoma cells from human urinary bladder washings by the polymerase chain reaction method , 1993, Cancer.

[66]  Y. Yarden,et al.  Expression of amphiregulin, cripto-1, and heregulin-alpha in human breast-cancer cells. , 1993, International journal of oncology.

[67]  I. Pastan,et al.  A recombinant form of Pseudomonas exotoxin A containing transforming growth factor alpha near its carboxyl terminus for the treatment of bladder cancer. , 1993, The Journal of urology.

[68]  T. Powles,et al.  The prognostic significance of transforming growth factors in human breast cancer. , 1993, British Journal of Cancer.

[69]  A. Levitzki,et al.  Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins. , 1993, The Journal of biological chemistry.

[70]  Y. Doki,et al.  Prognostic significance of transforming growth factor‐α in human esophageal carcinoma implication for the autocrine proliferation , 1993, Cancer.

[71]  C. Stein,et al.  Suramin: a novel antineoplastic agent with multiple potential mechanisms of action. , 1993, Cancer research.

[72]  E. Dmitrovsky,et al.  Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. , 1993, Cancer research.

[73]  F. Borchard,et al.  In situ evaluation of the relationship between epidermal‐growth‐factor‐receptor status and tumor‐cell proliferation in colon carcinomas , 1993, International journal of cancer.

[74]  D. Bar-Sagi,et al.  Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras , 1993, Nature.

[75]  Nanxin Li,et al.  Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling , 1993, Nature.

[76]  T. Pawson,et al.  The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1 , 1993, Nature.

[77]  F. McCormick.  How receptors turn Ras on , 1993, Nature.

[78]  Growth Control in a Human Colon Carcinoma Cell Line Mediated by Cell-Associated Transforming Growth Factor-α (TGFα) , 1993 .

[79]  D. Barnes,et al.  TGF alpha and TGF beta expression in mammary carcinoma , 1993, The Journal of pathology.

[80]  G. Unsgaard,et al.  Epidermal growth-factor and transforming growth factor-alpha in human meningiomas. , 1993, International journal of oncology.

[81]  James M. Roberts,et al.  Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. , 1993, Science.

[82]  J. Garcia-conde,et al.  Epidermal growth factor in human breast cancer, endometrial carcinoma and lung cancer. Its relationship to epidermal growth factor receptor, estradiol receptor and tumor TNM. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[83]  S. Thorgeirsson,et al.  Transgenic Mouse Model for Synergistic Effects of Nuclear Oncogenes and Growth Factors in Tumorigenesis: Interaction of c-myc and Transforming Growth Factor α in Hepatic Oncogenesis , 1993 .

[84]  M. Lai,et al.  Partial reversion of transformed phenotype of B104 cancer cells by antisense nucleic acids. , 1993, Cancer letters.

[85]  H. Ludwig,et al.  The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer , 1993, Cancer.

[86]  G. Rubin,et al.  An SH3-SH2-SH3 protein is required for p21 Ras1 activation and binds to sevenless and Sos proteins in vitro , 1993, Cell.

[87]  I. Ninomiya,et al.  Evidence of autocrine mechanism in poorly differentiated adenocarcinoma of the stomach. , 1993, International journal of oncology.

[88]  G. Carpenter.  EGF: new tricks for an old growth factor. , 1993, Current opinion in cell biology.

[89]  J. Filmus,et al.  Role of transforming growth factor alpha (TGF-alpha) in the transformation of ras-transfected rat intestinal epithelial cells. , 1993, Oncogene.

[90]  K. Kinzler,et al.  The APC gene product in normal and tumor cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[91]  K. Kinzler,et al.  The multistep nature of cancer. , 1993, Trends in genetics : TIG.

[92]  M. Tsao,et al.  In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas. , 1993, The American journal of pathology.

[93]  M. Waterfield,et al.  Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system , 1993, Nature.

[94]  H. Kimura,et al.  Schwannoma-derived growth factor must be transported into the nucleus to exert its mitogenic activity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[95]  D. Hanahan,et al.  Betacellulin: a mitogen from pancreatic beta cell tumors. , 1993, Science.

[96]  William Arbuthnot Sir Lane,et al.  ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family , 1993, Cell.

[97]  I. Pastan,et al.  Heparin-binding transforming growth factor alpha-Pseudomonas exotoxin A. A heparan sulfate-modulated recombinant toxin cytotoxic to cancer cells and proliferating smooth muscle cells. , 1993, The Journal of biological chemistry.

[98]  V. Gorgoulis,et al.  Expression of Epidermal Growth Factor (EGF) and Epidermal Growth Factor Receptor (EGFR) in Gastric and Colorectal Carcinomas1 , 1993 .

[99]  G. Plowman,et al.  Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[100]  Y. Yarden,et al.  Cell‐type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER‐2 suggests complex ligand‐receptor relationships. , 1993, The EMBO journal.

[101]  C. Doillon,et al.  Extracellular matrix analogs as carriers for growth factors: in vitro fibroblast behavior. , 1993, Journal of biomedical materials research.

[102]  S. Poulsen,et al.  Immunoreactive transforming growth factor alpha and epidermal growth factor in oral squamous cell carcinomas , 1993, The Journal of pathology.

[103]  J. Folkman,et al.  Cloning and expression of cDNA encoding human betacellulin, a new member of the EGF family. , 1993, Biochemical and Biophysical Research Communications - BBRC.

[104]  M. Shoyab,et al.  Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells. , 1993, The Journal of biological chemistry.

[105]  H. Ne.  Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy. , 1993, Seminars in cancer biology.

[106]  T. Hunter.  Editorial overview oncogenes and the cell cycle , 1993 .

[107]  J. Trepel,et al.  Antigrowth factor strategies , 1993, Cancer.

[108]  I. Shih,et al.  Role of growth factors and their receptors in the development and progression of melanoma. , 1993, The Journal of investigative dermatology.

[109]  M. Tsao,et al.  Proto-oncogene and growth factor/receptor expression in the establishment of primary human non-small cell lung carcinoma cell lines. , 1993, The American journal of pathology.

[110]  P. Macchia,et al.  Epidermal growth factor receptor and lipid membrane components in human lung cancers , 1993, Journal of endocrinological investigation.

[111]  W. Schmiegel,et al.  Tumor necrosis factor alpha induces the expression of transforming growth factor alpha and the epidermal growth factor receptor in human pancreatic cancer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[112]  H. Fox,et al.  Prognostic value of epidermal growth factor receptor expression in cervical carcinoma. , 1993, Journal of clinical pathology.

[113]  R. Bjerkvig,et al.  Effects of EGF, BFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain‐tumour biopsies In Vitro , 1993, International journal of cancer.

[114]  T. Bauknecht,et al.  Gene structure and expression analysis of the epidermal growth factor receptor, transforming growth factor‐alpha, myc, jun, and metallothionein in human ovarian carcinomas classification of malignant phenotypes , 1993, Cancer.

[115]  M. Klagsbrun,et al.  Heparin-binding EGF-like growth factor: characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues. , 1993, Biochemical and biophysical research communications.

[116]  J. Willson,et al.  Autocrine transforming growth factor-alpha is associated with progression of transformed properties in human colon cancer cells. , 1993, The Journal of biological chemistry.

[117]  F. Habib,et al.  Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels. , 1993, British Journal of Cancer.

[118]  M. Pincus,et al.  Detection of elevated c-erbB-2 oncoprotein in the serum and tissue in breast cancer , 1993 .

[119]  J. Grandis,et al.  TGF‐α and EGFR in head and neck cancer , 1993 .

[120]  K. Griffiths,et al.  An immunocytochemical analysis of TGFα expression in benign and malignant prostatic tumors , 1993 .

[121]  A. Levine.  The tumor suppressor genes. , 1993, Annual review of biochemistry.

[122]  C. Sardet,et al.  MAP kinases: activation, subcellular localization and role in the control of cell proliferation. , 1993, Advances in second messenger and phosphoprotein research.

[123]  P. Humphrey,et al.  Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues. , 1993, The Journal of urology.

[124]  D. Hopwood,et al.  Expression of epidermal growth factor, transforming growth factor alpha and their receptor in gastro-oesophageal diseases. , 1993, Digestive diseases.

[125]  A. Wilks.  Protein tyrosine kinase growth factor receptors and their ligands in development, differentiation, and cancer. , 1993, Advances in cancer research.

[126]  B. Mroczkowski,et al.  Identification of biologically active epidermal growth factor precursor in human fluids and secretions. , 1993, Endocrinology.

[127]  J. Massagué,et al.  Membrane-anchored growth factors. , 1993, Annual review of biochemistry.

[128]  Goldman,et al.  Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. , 1993, Molecular biology of the cell.

[129]  H. Friess,et al.  Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. , 1993, Anticancer research.

[130]  N. Dorward,et al.  Epidermal growth factor receptor activity and clinical outcome in glioblastoma and meningioma. , 1993, British journal of neurosurgery.

[131]  M. Noguchi,et al.  Tumor proliferation-related markers in papillary thyroid carcinomas: correlation with histologic subtypes. , 1993, Anticancer research.

[132]  T. Maruo,et al.  Immunohistochemical demonstration of elevated expression of epidermal growth factor receptor in the neoplastic changes of cervical squamous epithelium , 2010, Cancer.

[133]  Li Zhou,et al.  Growth regulation of ovarian cancer cells by epidermal growth factor and tranforming growth factors α and β1 , 1992 .

[134]  M. Nakafuku,et al.  Function of Ras as a molecular switch in signal transduction. , 1992, The Journal of biological chemistry.

[135]  S. Chakrabarty,et al.  Proliferation of human colon cancer cells: Role of epidermal growth factor and transforming growth factorα , 1992, International journal of cancer.

[136]  S. Asa,et al.  Transforming growth factor-α in normal and neoplastic human endocrine tissues , 1992 .

[137]  J. Tam,et al.  Decreased expression of transforming growth factor alpha during differentiation of human pancreatic cancer cells. , 1992, Gastroenterology.

[138]  J. Foekens,et al.  Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay. , 1992, British Journal of Cancer.

[139]  D. Barnes,et al.  Expression of the ERBB3 gene product in breast cancer. , 1992, British Journal of Cancer.

[140]  A. Wellstein,et al.  Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals. , 1992, Journal of the National Cancer Institute.

[141]  S. Hayashi,et al.  Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients. , 1992, Gastroenterology.

[142]  N. Lemoine,et al.  The erbB‐3 Gene in human pancreatic cancer , 1992, The Journal of pathology.

[143]  R. Coffey,et al.  Roles for transforming growth factor-alpha in gastric physiology and pathophysiology. , 1992, The Yale journal of biology and medicine.

[144]  A. Burgess,et al.  Anti-sense transforming growth factor alpha oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell line. , 1992, Molecular biology of the cell.

[145]  A. Garner,et al.  Therapeutic potential of growth factors and their antagonists. , 1992, The Yale journal of biology and medicine.

[146]  G. Plowman,et al.  Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells , 1992, Journal of cellular physiology.

[147]  H. Friess,et al.  Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. , 1992, The Journal of clinical investigation.

[148]  K. Kuroi,et al.  Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients. , 1992, American journal of surgery.

[149]  D. Rifkin,et al.  The extracellular regulation of growth factor action. , 1992, Molecular biology of the cell.

[150]  G. Merlino,et al.  Development of Liver Tumors in Transforming Growth Factor α Transgenic Mice , 1992 .

[151]  J. Foekens,et al.  Receptors for hormones and growth factors and (ONCO)‐gene amplification in human ovarian cancer , 1992, International journal of cancer.

[152]  A. Mcnicol,et al.  A comparison of biochemical and immunohistochemical assessment of EGFR expression in ovarian cancer. , 1992, Anticancer research.

[153]  E. Messing.  Growth factors and bladder cancer: clinical implications of the interactions between growth factors and their urothelial receptors. , 1992, Seminars in surgical oncology.

[154]  A. Bisceglie,et al.  Transforming growth factor‐alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver , 1992, Cancer.

[155]  L. Demers,et al.  Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[156]  M. Sporn,et al.  Autocrine Secretion—10 Years Later , 1992, Annals of Internal Medicine.

[157]  Yosef Yarden,et al.  Signal transduction by the neu/ebrB-2 receptor: A potential target for anti-tumor therapy , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[158]  E. Jaros,et al.  Prognostic factors in medulloblastoma , 1992, The Lancet.

[159]  A. Ullrich,et al.  The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling , 1992, Cell.

[160]  A. Thornley,et al.  In vitro secretion of transforming growth factor alpha (TGF-α): A comparison of the A431 cell line with three human oesophageal squamous cell carcinoma lines , 1992, Bioscience reports.

[161]  A. Bisceglie,et al.  Increased expression of transforming growth factor α after transfection of a human hepatoblastoma cell line with the hepatitis B virus , 1992, Journal of medical virology.

[162]  D. Salomon,et al.  Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon , 1992, The Journal of cell biology.

[163]  J. Bartlett,et al.  Growth control by epidermal growth factor and transforming growth factor-alpha in human lung squamous carcinoma cells. , 1992, British Journal of Cancer.

[164]  V. Gorgoulis,et al.  Expression of EGF, TGF-alpha and EGFR in squamous cell lung carcinomas. , 1992, Anticancer research.

[165]  G. Unsgaard,et al.  Expression of epidermal growth factor receptor in human meningiomas and meningeal tissue , 1992, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[166]  N. Lemoine,et al.  Expression of the c-erbB-3 protein in normal human adult and fetal tissues. , 1992, Oncogene.

[167]  H. Fox,et al.  Prognostic value of c-erbB-2 expression in uterine cervical carcinoma. , 1992, Journal of clinical pathology.

[168]  P. Hamilton,et al.  Expression of transforming growth factor alpha mRNA in benign and malignant tissues derived from gynecologic patients with various proliferative conditions. , 1992, Anticancer research.

[169]  J. Baselga,et al.  Growth regulation of human renal carcinoma cells: role of transforming growth factor alpha. , 1992, Cancer research.

[170]  H. Antoniades,et al.  Expression of c-sis/platelet-derived growth factor B, insulin-like growth factor I, and transforming growth factor alpha messenger RNAs and their respective receptor messenger RNAs in primary human gastric carcinomas: in vivo studies with in situ hybridization and immunocytochemistry. , 1992, Cancer research.

[171]  N. Normanno,et al.  Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors. , 1992, Cancer research.

[172]  D. Russell,et al.  Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor , 1992, Cell.

[173]  M. Tykocinski,et al.  Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[174]  S. Pelech,et al.  Mitogen-activated protein kinases: versatile transducers for cell signaling. , 1992, Trends in biochemical sciences.

[175]  D. Parham,et al.  Transforming growth factor alpha in epithelial proliferative diseases of the breast. , 1992, Journal of clinical pathology.

[176]  L. Akslen,et al.  Expression of c-erbB-2 protein in papillary thyroid carcinomas. , 1992, British Journal of Cancer.

[177]  R. Coffey,et al.  Differential regulation of transforming growth factor alpha autoinduction in a nontransformed and transformed epithelial cell. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[178]  R. Coffey,et al.  Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. , 1992, Cancer research.

[179]  D. Goeddel,et al.  Identification of Heregulin, a Specific Activator of p185erbB2 , 1992, Science.

[180]  C. James,et al.  Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[181]  K. Korach,et al.  Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[182]  James T. Elder,et al.  Regulation of TGF‐α expression in human keratinocytes: PKC‐dependent and ‐independent pathways , 1992 .

[183]  K. Kinzler,et al.  Erratum: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene , 1992, Science.

[184]  G. Fuller,et al.  Amplified cellular oncogenes in neoplasms of the human central nervous system. , 1992, Mutation research.

[185]  V. Gorgoulis,et al.  Expression of epidermal growth factor, transforming growth factor-alpha and epidermal growth factor receptor in thyroid tumors. , 1992, In vivo.

[186]  Yosef Yarden,et al.  Isolation of the Neu HER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cells , 1992, Cell.

[187]  M. Alison,et al.  Transforming growth factor α expression in normal gastric mucosa, intestinal metaplasia, dysplasia and gastric carcinoma—an immunohistochemical study , 1992 .

[188]  P. Humphrey,et al.  Structural alterations of the epidermal growth factor receptor gene in human gliomas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[189]  G. Scambia,et al.  Significance of epidermal growth factor receptor in advanced ovarian cancer. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[190]  M. Klagsbrun,et al.  Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. , 1992, The Journal of biological chemistry.

[191]  J. Blenis,et al.  ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK , 1992, Cell.

[192]  T. Mikkelsen,et al.  Increasing incidence of primary malignant brain tumors: influence of diagnostic methods. , 1992, Journal of the National Cancer Institute.

[193]  M. Bennett,et al.  c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma. , 1992, Journal of hepatology.

[194]  M. Willingham,et al.  EGF-R antisense RNA blocks expression of the epidermal growth factor receptor and suppresses the transforming phenotype of a human carcinoma cell line. , 1992, The Journal of biological chemistry.

[195]  W. Karnes,et al.  Autonomous proliferation of colon cancer cells that coexpress transforming growth factor alpha and its receptor. Variable effects of receptor-blocking antibody. , 1992, Gastroenterology.

[196]  D M Barnes,et al.  Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance? , 1992, European journal of cancer.

[197]  A. Saxena,et al.  Increased expression of genes from growth factor signaling pathways in glioblastoma cell lines. , 1992, Oncogene.

[198]  S. Langdon,et al.  Mitogenic effects of epidermal growth factor and transforming growth factor-alpha on EGF-receptor positive human ovarian carcinoma cell lines. , 1992, European journal of cancer.

[199]  M. De Bortoli,et al.  Tamoxifen up-regulates c-erbB-2 expression in oestrogen-responsive breast cancer cells in vitro. , 1992, European journal of cancer.

[200]  W. J. Boyle.  Growth factors and tyrosine kinase receptors during development and cancer , 1992, Current opinion in oncology.

[201]  J G Klijn,et al.  The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. , 1992, Endocrine reviews.

[202]  G. Johnson,et al.  Transforming growth factor-alpha acts as an autocrine growth factor in ovarian carcinoma cell lines. , 1992, Cancer research.

[203]  G. Scambia,et al.  Preliminary evaluation of HER-2/neu oncogene and epidermal growth factor receptor expression in normal and neoplastic human ovaries , 1992, The International journal of biological markers.

[204]  J. Moossy,et al.  Amplification of Epidermal Growth Factor Receptor Gene in Gliomas: Histopathology and Prognosis , 1992, Journal of neuropathology and experimental neurology.

[205]  R. Derynck.  The Physiology Of Transforming Growth Factor-α , 1992 .

[206]  H. Fuse,et al.  Epidermal growth factor in urine from the patients with urothelial tumors. , 1992, Urologia internationalis.

[207]  W. Dippold,et al.  Expression of differentiation antigens and growth-related genes in normal kidney, autosomal dominant polycystic kidney disease, and renal cell carcinoma. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[208]  G. N. Hansen,et al.  Immunohistochemical detection of epidermal growth factor receptor in laryngeal squamous cell carcinomas. , 1992, Acta oto-laryngologica.

[209]  A. Benabid,et al.  EGF receptor amplification and expression in human brain tumours. , 1992, European journal of cancer.

[210]  R. Coffey,et al.  Transforming growth factors and related peptides in gastrointestinal neoplasia , 1992, Journal of cellular biochemistry. Supplement.

[211]  L. Petch,et al.  Transforming growth factor-alpha and its role in neoplastic progression. , 1992, Cancer treatment and research.

[212]  M. Volm,et al.  Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations. , 1992, Anticancer research.

[213]  K. Haruma,et al.  Immunoreactive transforming growth factor-alpha and epidermal growth factor in colorectal adenomas and carcinomas. , 1992, Oncology.

[214]  G. Plowman,et al.  Colorectum cell-derived growth factor (CRDGF) is homologous to amphiregulin, a member of the epidermal growth factor family. , 1992, Growth factors.

[215]  B. Modrell,et al.  The interaction of amphiregulin with nuclei and putative nuclear localization sequence binding proteins. , 1992, Growth factors.

[216]  N. Lemoine,et al.  The type 1 (EGFR-related) family of growth factor receptors and their ligands. , 1992, Progress in growth factor research.

[217]  G. Plowman,et al.  Regulation of amphiregulin mRNA by TGF-beta in the human lung adenocarcinoma cell line A549. , 1992, Growth factors.

[218]  W. Gullick,et al.  c-erbB2 amplification and overexpression in human tumors. , 1992, Cancer treatment and research.

[219]  T. Bauknecht,et al.  Epidermal growth factor receptor and transforming growth factor alpha expression in human ovarian carcinomas. , 1992, European journal of cancer.

[220]  M. Liu,et al.  Immunohistochemical study of transforming growth factor-alpha in human lung cancers. , 1992, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[221]  B. Vogelstein,et al.  DCC: a tumor suppressor gene expressed on the cell surface. , 1992, Cold Spring Harbor symposia on quantitative biology.

[222]  T. Bauknecht,et al.  Oncogene and growth factor expression in ovarian cancer , 1992, Acta obstetricia et gynecologica Scandinavica. Supplement.

[223]  P. Macchia,et al.  Epidermal growth factor receptor in human brain tumors , 1992, Journal of endocrinological investigation.

[224]  C. Knabbe,et al.  Growth factors in human prostate cancer cells: Implications for an improved treatment of prostate cancer , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[225]  J. Veldscholte,et al.  Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[226]  N. Normanno,et al.  Regulation by Estrogen through the 5′-Flanking Region of the Transforming Growth Factor α Gene , 1991 .

[227]  C. Browne.  Epidermal growth factor and transforming growth factor alpha. , 1991, Bailliere's clinical endocrinology and metabolism.

[228]  W. Bodmer,et al.  Growth factor requirements of human colorectal tumour cells: relations to cellular differentiation. , 1991, European journal of cancer.

[229]  M. Reiss,et al.  Activation of the autocrine transforming growth factor alpha pathway in human squamous carcinoma cells. , 1991, Cancer research.

[230]  R. Leake,et al.  Growth factors in ovarian cancer. , 1991, British Journal of Cancer.

[231]  S. Aaronson,et al.  Growth factors and cancer. , 1991, Science.

[232]  K. Sugimachi,et al.  Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. , 1991, European journal of cancer.

[233]  M. Inoue,et al.  in Vitro Ovarian Cancer Cell Line Growth Factor Receptor Autocrine Growth Mechanism in an / Epidermal α Involvement of Transforming Growth Factor , 2006 .

[234]  D. Salomon,et al.  Response to and expression of amphiregulin by ovarian carcinoma and normal ovarian surface epithelial cells: nuclear localization of endogenous amphiregulin. , 1991, Biochemical and biophysical research communications.

[235]  D. Wynford‐Thomas,et al.  Abnormalities of the EGF receptor system in human thyroid neoplasia , 1991, International journal of cancer.

[236]  M. Klagsbrun,et al.  A dual receptor system is required for basic fibroblast growth factor activity , 1991, Cell.

[237]  L. Murphy,et al.  Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins. , 1991, Cancer research.

[238]  G. Powis,et al.  Growth factor and oncogene signalling pathways as targets for rational anticancer drug development. , 1991, Clinical biochemistry.

[239]  H. Sasano,et al.  Expression of c-myc, epidermal growth factor receptor and c-erbB-2 in human endometrial carcinoma and cervical adenocarcinoma. , 1991, The Tohoku journal of experimental medicine.

[240]  T. Yamamoto,et al.  Evidence for the involvement of transforming growth factor alpha and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro. , 1991, Cancer research.

[241]  A. Albino,et al.  Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. , 1991, Cancer research.

[242]  D. Salomon,et al.  Differential expression of epidermal growth factor-related proteins in human colorectal tumors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[243]  Kazuhiro Yoshida,et al.  Expression of cripto, a Novel Gene of the Epidermal Growth Factor Family, in Human Gastrointestinal Carcinomas , 1991, Japanese journal of cancer research : Gann.

[244]  P. Toy,et al.  A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian tumor cell lines. , 1991, Cancer research.

[245]  A. Ciccodicola,et al.  Isolation and characterization of the CRIPTO autosomal gene and its X-linked related sequence. , 1991, American journal of human genetics.

[246]  G. Herrera.  C-erb B-2 amplification in cystic renal disease. , 1991, Kidney international.

[247]  K. Yamaguchi,et al.  Effect of urine on clonal growth of human bladder cancer cell lines. , 1991, Cancer research.

[248]  S. Ménard,et al.  Prognostic significance of her‐2/neu expression in breast cancer and its relationship to other prognostic factors , 1991, International journal of cancer.

[249]  P. Humphrey,et al.  Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function. , 1991, Biochemical and biophysical research communications.

[250]  M. M. Alsina,et al.  The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice. , 1991, Cancer research.

[251]  T. Horn,et al.  Transforming Growth Factor a Expression Helps to Distinguish Keratoacanthomas From Squamous Cell Carcinomas , 1991 .

[252]  Enrietto Pj,et al.  Cell transformation by the epidermal growth factor receptor and v-erbB. , 1991 .

[253]  A. Burgess,et al.  The proliferative and morphologic responses of a colon carcinoma cell line (LIM 1215) require the production of two autocrine factors , 1991, Molecular and cellular biology.

[254]  J. Price,et al.  Growth modulation by epidermal growth factor (EGF) in human colonic carcinoma cells: Constitutive expression of the human EGF gene , 1991, Journal of cellular physiology.

[255]  T. Bauknecht,et al.  Expression analysis of EGF-R and TGFa in human ovarian carcinomas. , 1991, Anticancer research.

[256]  F Matsubara,et al.  Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas. , 1991, Anticancer research.

[257]  K. Haruma,et al.  Immunoreactive transforming growth factor alpha is commonly present in colorectal neoplasia. , 1991, The American journal of pathology.

[258]  J. Kim,et al.  Inhibition of prostatic tumor cell proliferation by suramin: alterations in TGF alpha-mediated autocrine growth regulation and cell cycle distribution. , 1991, The Journal of urology.

[259]  M. Herlyn,et al.  Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. , 1991, The Journal of investigative dermatology.

[260]  N. Lemoine,et al.  Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer. , 1991, British Journal of Cancer.

[261]  A. Ullrich,et al.  Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth. , 1991, Growth regulation.

[262]  J. Mendelsohn,et al.  Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha. , 1991, Cancer research.

[263]  R. Akita,et al.  An antigen immunologically related to the external domain of gp185 is shed from nude mouse tumors overexpressing the c-erbB-2 (HER-2/neu) oncogene. , 1991, Cancer research.

[264]  K. M. Mulder.  Differential regulation of c-myc and transforming growth factor-alpha messenger RNA expression in poorly differentiated and well-differentiated colon carcinoma cells during the establishment of a quiescent state. , 1991, Cancer research.

[265]  J. Adelman,et al.  A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin , 1991, Molecular and cellular biology.

[266]  C. Flamigni,et al.  The Effect of Progestin on Factors Influencing Growth and Invasion of Endometrial Carcinoma , 1991, Annals of the New York Academy of Sciences.

[267]  T. Yoneda,et al.  Dependence of a human squamous carcinoma and associated paraneoplastic syndromes on the epidermal growth factor receptor pathway in nude mice. , 1991, Cancer research.

[268]  C. James,et al.  Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. , 1991, Cancer research.

[269]  Y. Yarden,et al.  Biochemical analysis of the ligand for the neu oncogenic receptor. , 1991, Biochemistry.

[270]  R. Prescott,et al.  Epidermal growth factor receptors in intracranial and breast tumours: their clinical significance. , 1991, British Journal of Cancer.

[271]  M. Knowles,et al.  Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder. , 1991, British Journal of Cancer.

[272]  K. Kinzler,et al.  Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. , 1991, Science.

[273]  Erkki Ruoslahti,et al.  Proteoglycans as modulators of growth factor activities , 1991, Cell.

[274]  G. Paludetti,et al.  Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumors , 1991, Cancer.

[275]  L. Burgart,et al.  Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[276]  T. Maudelonde,et al.  Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer. , 1991, Oncogene.

[277]  M. Korc,et al.  Regulation of Transforming Growth Factor-α mRNA Expression in T3M4 Human Pancreatic Carcinoma Cells , 1991 .

[278]  F Demard,et al.  Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas , 1991, Head & neck.

[279]  M. Crépin,et al.  Primary cultures of human benign mastopathies and mammary carcinomas; growth factor requirements. , 1991, Anticancer research.

[280]  A. Harris,et al.  c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. , 1991, British Journal of Cancer.

[281]  M. Klagsbrun,et al.  A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF , 1991, Science.

[282]  S. Naber,et al.  Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. , 1991, Cancer research.

[283]  A. Levine,et al.  Differential role of transforming growth factor‐α in two human colon‐carcinoma cell lines , 1991 .

[284]  N. Lemoine,et al.  Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer , 1991, The Journal of pathology.

[285]  N. Katsuta,et al.  Expression of c-erbB-2 gene product in urinary bladder cancer. , 1991, The Journal of urology.

[286]  D. Salomon,et al.  Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line. , 1991, Cancer research.

[287]  N. Lemoine,et al.  Avoiding Punishment Is Its Own Reward , 1991, British Journal of Cancer.

[288]  T. Cooke,et al.  The effects of intracolonic EGF on mucosal growth and experimental carcinogenesis. , 1991, British Journal of Cancer.

[289]  J. Bishop.  Molecular themes in oncogenesis , 1991, Cell.

[290]  C. Marshall.  Tumor suppressor genes , 1991, Cell.

[291]  T. Hunter.  Cooperation between oncogenes , 1991, Cell.

[292]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[293]  J. Farndon,et al.  Synthetic oligonucleotides as therapeutic agents. , 1991, British Journal of Cancer.

[294]  S. Watson,et al.  Co-stimulation of gastrointestinal tumour cell growth by gastrin, transforming growth factor alpha and insulin like growth factor-I. , 1991, British Journal of Cancer.

[295]  K. Sugimachi,et al.  Prognostic implication of transforming growth factor alpha in adenocarcinoma of the lung--an immunohistochemical study. , 1991, British Journal of Cancer.

[296]  S. Naber,et al.  Detection and quantitation of the human neu oncoprotein , 1991 .

[297]  R. Dickson,et al.  Genes, oncogenes, and hormones : advances in cellular and molecular biology of breast cancer , 1991 .

[298]  R. Halaban,et al.  Proliferation and malignant transformation of melanocytes. , 1991, Critical reviews in oncogenesis.

[299]  W. Gullick,et al.  Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. , 1991, British medical bulletin.

[300]  R. Dickson,et al.  The EGF receptor system as a target for antitumor therapy. , 1991, Cancer investigation.

[301]  J. DiGiovanni,et al.  Evidence for autocrine/paracrine growth stimulation by transforming growth factor‐α during the process of skin tumor promotion , 1991, Molecular carcinogenesis.

[302]  M. Korc,et al.  Growth factors and pancreatic cancer , 1991, International journal of pancreatology : official journal of the International Association of Pancreatology.

[303]  J. Boyd,et al.  Analysis of oncogene alterations in human endometrial carcinoma: Prevalence of ras mutations , 1991, Molecular carcinogenesis.

[304]  D. Salomon,et al.  The role of ras gene expression and transforming growth factor alpha production in the etiology and progression of rodent and human breast cancer. , 1991, Cancer treatment and research.

[305]  R. Dickson,et al.  Regulatory Mechanisms in Breast Cancer , 1991, Cancer Treatment and Research.

[306]  T. Bauknecht,et al.  Clinical significance of oncogenes and growth factors in ovarian carcinomas , 1990, The Journal of Steroid Biochemistry and Molecular Biology.

[307]  Y. Yarden,et al.  Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. , 1990, Biochemistry.

[308]  J. Massagué,et al.  Transforming growth factor-alpha. A model for membrane-anchored growth factors. , 1990, The Journal of biological chemistry.

[309]  T. Kameda,et al.  Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification. , 1990, Cancer research.

[310]  P. Humphrey,et al.  Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. , 1990, Cancer research.

[311]  K. M. Mulder,et al.  Inhibitory Effects of Transforming Growth Factor β1 on Mitogenic Response, Transforming Growth Factor α, and c-myc in Quiescent, Well-Differentiated Colon Carcinoma Cells , 1990 .

[312]  M. Rosenblum,et al.  Expression of transforming growth factor alpha in human gliomas. , 1990, Oncogene.

[313]  D. Salomon,et al.  Transforming growth factor-alpha: an oncodevelopmental growth factor. , 1990, Cancer cells.

[314]  T. Yamamoto,et al.  erbB-2 gene expression in colorectal cancer. , 1990, The Japanese journal of experimental medicine.

[315]  C. James,et al.  Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[316]  S. Singletary,et al.  Transforming growth factor-alpha secretion by epidermal growth factor-dependent human tumor cell lines. , 1990, Anticancer research.

[317]  T. Bauknecht,et al.  In situ distribution of transforming growth factor α in normal human tissues and in malignant tumours of the ovary , 1990, The Journal of pathology.

[318]  C. Macleod,et al.  Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin. , 1990, The Journal of clinical investigation.

[319]  K. Sugimachi,et al.  Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung. , 1990, Cancer research.

[320]  Harold L. Moses,et al.  TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights , 1990, Cell.

[321]  D. Salomon,et al.  Over‐expression of the epidermal growth factor receptor in human breast cancer cells fails to induce an Estrogen‐independent phenotype , 1990, International journal of cancer.

[322]  W. Bodmer,et al.  p53 mutations in colorectal cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[323]  M. Herlyn,et al.  Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor‐derived EGF/TGF‐α , 1990, Journal of cellular biochemistry.

[324]  T. Löning,et al.  Expression of c-erbB2 and c-myc in squamous epithelia and squamous cell carcinomas of the head and neck and the lower female genital tract. , 1990, Journal of Oral Pathology & Medicine.

[325]  L. Murphy,et al.  Epidermal growth factor: receptor and ligand expression in human breast cancer. , 1990, Seminars in cancer biology.

[326]  M. Ladanyi,et al.  Gene amplification in gastric and esophageal adenocarcinomas. , 1990, Cancer research.

[327]  M. Kraus,et al.  Implications of erbB-2 overexpression for basic science and clinical medicine. , 1990, Seminars in cancer biology.

[328]  J. Mendelsohn.  The epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies. , 1990, Seminars in cancer biology.

[329]  H. Wanebo,et al.  Epidermal growth factor stimulation and metastatic rate in human pancreatic carcinoma cell lines. , 1990, The Journal of surgical research.

[330]  D. Clarke-Pearson,et al.  Expression of epidermal growth factor receptor and HER‐2/neu in normal and neoplastic cervix, vulva, and vagina , 1990, Obstetrics and gynecology.

[331]  J. Brotchi,et al.  Epidermal growth factor receptors in human tumors of the central nervous system. , 1990, Anticancer research.

[332]  Masui,et al.  Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[333]  M. Tsao,et al.  Expression of transforming growth factor-alpha in primary human colon and lung carcinomas. , 1990, British Journal of Cancer.

[334]  D. Weiner,et al.  p185neu expression in human lung adenocarcinomas predicts shortened survival. , 1990, Cancer research.

[335]  J. Lakshmanan,et al.  Metabolism and effects of epidermal growth factor and related growth factors in mammals. , 1990, Endocrine reviews.

[336]  D. C. Lee,et al.  Expression of the TGF alpha integral membrane precursor induces transformation of NRK cells. , 1990, Oncogene.

[337]  T. Fleming,et al.  Transformation of NIH3T3 fibroblasts by an expression vector for the human epidermal growth factor precursor. , 1990, Oncogene.

[338]  T. Strohmeyer,et al.  Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma. , 1990, Cancer research.

[339]  H. Ito,et al.  Alterations of oncogenes in metastatic tumours of human gastric carcinomas. , 1990, British Journal of Cancer.

[340]  Helmut Dotzlaw,et al.  Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression. , 1990, Cancer research.

[341]  J. Massagué,et al.  Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation , 1990, Cell.

[342]  D. Ellis,et al.  Detection of urinary TGF-α by HPLC and western blot in patients with melanoma , 1990 .

[343]  N. Lemoine,et al.  The c‐erbB‐2 proto‐oncogene in human pancreatic cancer , 1990, The Journal of pathology.

[344]  G. Plowman,et al.  Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[345]  D. Taverna,et al.  Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells. , 1990, Oncogene.

[346]  R. Coffey,et al.  Expression of and Response to Growth Regulatory Peptides by Two Human Pancreatic Carcinoma Cell Lines , 1990, Pancreas.

[347]  J. Willson,et al.  Growth stimulation by coexpression of transforming growth factor-alpha and epidermal growth factor-receptor in normal and adenomatous human colon epithelium. , 1990, The Journal of clinical investigation.

[348]  G. Merlo,et al.  Transforming growth factor-alpha messenger RNA localization in the developing adult rat and human mammary gland by in situ hybridization. , 1990, Developmental biology.

[349]  C. Cordon-Cardo,et al.  Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. , 1990, Oncogene.

[350]  T. Tajiri,et al.  [Immunohistochemical study on epidermal growth factor and its receptor in human pancreatic carcinoma]. , 1990, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[351]  G. Jakse,et al.  Modulation of pro-epidermal growth factor, pro-transforming growth factor alpha and epidermal growth factor receptor gene expression in human renal carcinomas. , 1990, Cancer research.

[352]  S. Naber,et al.  neu oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissues. , 1990, Human pathology.

[353]  R. Bast,et al.  Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. , 1990, Cancer research.

[354]  M. Greene,et al.  Intermolecular association of the p185 neu protein and EGF receptor modulates EGF receptor function , 1990, Cell.

[355]  R. Palmiter,et al.  Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast , 1990, Cell.

[356]  F. Chisari,et al.  Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice. , 1990, Cancer research.

[357]  M. Gregoriou,et al.  Investigation of the expression of epidermal growth factor receptor and blood group A antigen in 110 human gliomas , 1990, Neuropathology and applied neurobiology.

[358]  P. Humphrey,et al.  Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[359]  J. Dodd,et al.  Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. , 1990, The Journal of urology.

[360]  R. Bravo.  Growth factor-responsive genes in fibroblasts. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[361]  A. Logan.  Intracrine regulation at the nucleus--a further mechanism of growth factor activity? , 1990, The Journal of endocrinology.

[362]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[363]  A. Look,et al.  Oncogene amplification in pediatric brain tumors. , 1990, Cancer research.

[364]  T. Masuko,et al.  Immunohistochemical Analysis of c‐erbB‐2 Oncogene Product and Epidermal Growth Factor Receptor Expression in Human Urinary Bladder Carcinomas , 1990, Acta pathologica japonica.

[365]  M. Moorghen,et al.  Epidermal growth factor receptors in colorectal carcinoma. , 1990, Anticancer research.

[366]  C. Disteche,et al.  The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity , 1990, Molecular and cellular biology.

[367]  T. Akiyama,et al.  In vitro and in vivo Release of Soluble erbB‐2 Protein from Human Carcinoma Cells , 1990, Japanese journal of cancer research : Gann.

[368]  N. Yanaihara,et al.  Epidermal Growth Factor and Its Receptors in Human Pancreatic Carcinoma , 1990, Pancreas.

[369]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[370]  E. Messing.  Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma. , 1990, Cancer research.

[371]  A. Harris,et al.  The epidermal growth factor receptor and the prognosis of bladder cancer , 1990, Cancer.

[372]  S. Piantadosi,et al.  Clinical evidence for and implications of the multistep development of prostate cancer. , 1990, The Journal of urology.

[373]  Y. Luqmani,et al.  Transcripts for transforming growth factors in human breast cancer: clinical correlates. , 1990, British Journal of Cancer.

[374]  A. Ullrich,et al.  Expression of the p185 encoded by her2 oncogene in normal and transformed human tissues , 1990, International journal of cancer.

[375]  N. Lemoine,et al.  Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer. , 1990, Oncogene.

[376]  E. Tahara,et al.  EGF and TGF‐α, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors , 1990 .

[377]  Kathleen R. Cho,et al.  Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.

[378]  N. Wright,et al.  Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells , 1990, Nature.

[379]  F. Ciardiello,et al.  Differential growth factor expression in transformed mouse NIH‐3T3 cells , 1990, Journal of cellular biochemistry.

[380]  D. Paul,et al.  Basic fibroblast growth factor and transforming growth factor‐α are hepatotrophic mitogens in vitro , 1990, Journal of cellular physiology.

[381]  W. Yung,et al.  Differental amplification of the TGF-α gene in human gliomas , 1990 .

[382]  S. Bates,et al.  Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells. , 1990, Endocrinology.

[383]  E. Ohmura,et al.  Insulin-like Growth Factor I and Transforming Growth Factor α as Autocrine Growth Factors in Human Pancreatic Cancer Cell Growth , 1990 .

[384]  S. Aaronson,et al.  Mechanisms by which EGF receptor and TGF alpha contribute to malignant transformation. , 1990, Natural immunity and cell growth regulation.

[385]  Kazuhiro Yoshida,et al.  Expression of several growth factors and their receptor genes in human colon carcinomas , 1990, Virchows Archiv. B, Cell pathology including molecular pathology.

[386]  S. Bates,et al.  Modulation of EGF receptor expression by differentiating agents in human colon carcinoma cell lines. , 1990, Cancer communications.

[387]  M. Hung,et al.  Amplification and expression of the c‐erb B‐2/neu proto‐oncogene in human bladder cancer , 1990, Molecular carcinogenesis.

[388]  G. Vinson,et al.  Epidermal growth factor in breast cancer. , 1990, The International journal of biochemistry.

[389]  W. Gullick.  4. The role of the epidermal growth factor receptor and the c‐erbB‐2 protein in breast cancer , 1990 .

[390]  W. Linehan,et al.  Epidermal growth factor receptor gene analysis in renal cell carcinoma. , 1990, The Journal of urology.

[391]  J. Olofsson,et al.  Expression of epidermal growth factor receptor in laryngeal dysplasia and carcinoma. , 1990, Acta oto-laryngologica.

[392]  D. Rose,et al.  Production of epidermal growth factor and transforming growth factor‐α by the androgen‐responsive LNCaP human prostate cancer cell line , 1990, The Prostate.

[393]  R. Palmiter,et al.  Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice , 1989, Cell.

[394]  A. Kasid,et al.  Expression of Transforming Growth Factor α in Normal Human Adult Kidney and Enhanced Expression of Transforming Growth Factors α and β1 in Renal Cell Carcinoma , 1989 .

[395]  F. Collins,et al.  Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.

[396]  C. Mettlin,et al.  National survey of patterns of care for brain-tumor patients. , 1989, Journal of neurosurgery.

[397]  M. Kraus,et al.  Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[398]  M. Aapro,et al.  Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas. , 1989, Cancer research.

[399]  S Kerby,et al.  Infection with a TGF-alpha retroviral vector transforms normal mouse mammary epithelial cells but not normal rat fibroblasts. , 1989, Oncogene.

[400]  A. Belldegrun,et al.  Epidermal growth factor receptor gene expression in normal human kidney and renal cell carcinoma. , 1989, The Journal of urology.

[401]  A. Harris,et al.  Characterization and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumors. , 1989, Cancer research.

[402]  J. Elder,et al.  Transforming growth factor alpha and epidermal growth factor levels in normal human gastrointestinal mucosa. , 1989, British Journal of Cancer.

[403]  T. Bauknecht,et al.  The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance. , 1989, Anticancer research.

[404]  I. Summerhayes,et al.  Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon. , 1989, Oncogene.

[405]  N. Shimizu,et al.  Expression of epidermal growth factor receptors in four histologic cell types of lung cancer , 1989, Journal of Surgical Oncology.

[406]  J. L. Bos,et al.  ras oncogenes in human cancer: a review. , 1989, Cancer research.

[407]  G. Merlo,et al.  mRNA expression of transforming growth factor alpha in human breast carcinomas and its activity in effusions of breast cancer patients. , 1989, Journal of the National Cancer Institute.

[408]  R. Todd,et al.  TGF-α and EGF-receptor mRNAs in human oral cancer , 1989 .

[409]  R. Greig,et al.  Expression of TGF‐α/EGF and TGF‐p receptors in human colon carcinoma cell lines , 1989 .

[410]  Silvana,et al.  Molecular characterization of a gene of the ‘EGF family’ expressed in undifferentiated human NTERA2 teratocarcinoma cells. , 1989, The EMBO journal.

[411]  J. Perheentupa,et al.  EGF- and TGF-α-Like Peptides in Human Fetal Gut , 1989, Pediatric Research.

[412]  E. Rutanen,et al.  Binding of epidermal growth factor and insulin‐like growth‐factor I in renal carcinoma and adjacent normal kidney tissue , 1989, International journal of cancer.

[413]  C. Cordon-Cardo,et al.  Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue. , 1989, Cancer research.

[414]  N. Wright,et al.  Colorectal Cancer: From Pathogenesis to Prevention? , 1989 .

[415]  T. Bauknecht,et al.  Human ovarian carcinomas: correlation of malignancy and survival with the expression of epidermal growth factor receptors (EGF-R) and EGF-like factors (EGF-F) , 1989, Medical oncology and tumor pharmacotherapy.

[416]  D. Bowen-Pope,et al.  Growth factor production by human colon carcinoma cell lines. , 1989, Cancer research.

[417]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.

[418]  W. Meier,et al.  Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix. , 1989, Gynecologic oncology.

[419]  D. Podolsky,et al.  Differential expression of transforming growth factors alpha and beta in rat intestinal epithelial cells. , 1989, The Journal of clinical investigation.

[420]  P. Hasleton,et al.  Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumour size, node status and survival. , 1989, British Journal of Cancer.

[421]  K. Abe,et al.  Production of transforming growth factor-alpha in human tumour cell lines. , 1989, British Journal of Cancer.

[422]  Y. Luqmani,et al.  Expression of growth factor and epidermal growth factor receptor encoded transcripts in human gastric tissues. , 1989, Cancer research.

[423]  L. Murphy,et al.  Regulation of Transforming Growth Factor α and Transforming Growth Factor β Messenger Ribonucleic Acid Abundance in T-47D, Human Breast Cancer Cells , 1989, Molecular Endocrinology.

[424]  J. Barrett,et al.  Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas. , 1989, The American journal of pathology.

[425]  K. Asano,et al.  Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. , 1989, British Journal of Cancer.

[426]  A. Howell,et al.  Epidermal and transforming growth factor alpha in patients with breast tumours. , 1989, British Journal of Cancer.

[427]  A. Burgess,et al.  Expression of transforming growth factor alpha messenger rna in the normal and neoplastic gastro‐intestinal tract , 1989, International journal of cancer.

[428]  L. Skoog,et al.  Receptors for epidermal growth factor and sex steroid hormones in human colorectal carcinomas. , 1989, Anticancer research.

[429]  A. Harris,et al.  Epidermal growth factor receptor in human bladder cancer: a comparison of immunohistochemistry and ligand binding. , 1989, The Journal of urology.

[430]  J. Mead,et al.  Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[431]  G. Gibson,et al.  Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer. , 1989, Cancer research.

[432]  G. Plowman,et al.  Structure and function of human amphiregulin: a member of the epidermal growth factor family. , 1989, Science.

[433]  M. Mathieu,et al.  Structure and expression of c‐erbB‐2 and EGF receptor genes in inflammatory and non‐inflammatory breast cancer: Prognostic significance , 1989, International journal of cancer.

[434]  James T. Elder,et al.  Overexpression of transforming growth factor alpha in psoriatic epidermis. , 1989, Science.

[435]  K. Yamaguchi,et al.  Inhibition of growth of human lung adenocarcinoma cell lines by anti-transforming growth factor-alpha monoclonal antibody. , 1989, Journal of the National Cancer Institute.

[436]  J. Farndon,et al.  EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTORS ASSOCIATED WITH LACK OF RESPONSE TO ENDOCRINE THERAPY IN RECURRENT BREAST CANCER , 1989, The Lancet.

[437]  今西 幸市.  Production of transforming growth factor-α in human tumor cell lines , 1989 .

[438]  S. Bates,et al.  Transforming Growth Factor α Production and Epidermal Growth Factor Receptor Expression in Normal and Oncogene Transformed Human Mammary Epithelial Cells , 1989 .

[439]  L. Augenlicht.  Cell and Molecular Biology of Colon Cancer , 1989 .

[440]  R. Weinberg.  Oncogenes and the molecular origins of cancer , 1989 .

[441]  N. Wright.  The Control of Cell Proliferation in Colonic Epithelium , 1989 .

[442]  E. Gelmann,et al.  Role of transforming growth factor ‐α in human prostate cancer cell growth , 1989 .

[443]  L Skoog,et al.  Transforming growth factor alpha in human mammary carcinomas and their metastases. , 1989, Anticancer research.

[444]  D. Salomon,et al.  Transforming growth factors in human breast cancer. , 1989, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[445]  D. Weiner,et al.  Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed epithelial tissues of the digestive tract. , 1989, Oncogene.

[446]  C. Eaton,et al.  Binding of epidermal growth factor by human normal, hypertrophic, and carcinomatous prostate , 1989, The Prostate.

[447]  M. Hung,et al.  Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract. , 1989, Oncogene.

[448]  T. Fleming,et al.  Autocrine interaction between TGF alpha and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. , 1989, Oncogene.

[449]  G. Merlo,et al.  Transformation of an established mouse mammary epithelial cell line following transfection with a human transforming growth factor alpha cDNA , 1989, Molecular carcinogenesis.

[450]  J. Farndon,et al.  Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions with neu. , 1989, Journal of steroid biochemistry.

[451]  S. Iacobelli,et al.  Epidermal growth factor receptor expression in gynecological malignancies. , 1989, Gynecologic and obstetric investigation.

[452]  C. Fognani,et al.  Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas. , 1989, Journal of the National Cancer Institute.

[453]  R. Dickson,et al.  Breast Cancer: Cellular and Molecular Biology , 2011, Cancer Treatment and Research.

[454]  Y. Nakanuma,et al.  Simultaneous detection of epidermal growth factor receptor (EGF-R), epidermal growth factor (EGF) and ras p21 in cholangiocarcinoma by an immunocytochemical method. , 2008, Liver.

[455]  M. Brattain,et al.  Different epidermal growth factor growth responses and receptor levels in human colon carcinoma cell lines. , 1988, Cancer letters.

[456]  J. Marvaldi,et al.  Autocrine secretion of a colorectum‐derived growth factor by HT‐29 human colon carcinoma cell line , 1988, International journal of cancer.

[457]  F. Ciardiello,et al.  Induction of transforming growth factor alpha expression in mouse mammary epithelial cells after transformation with a point-mutated c-Ha-ras protooncogene. , 1988, Molecular endocrinology.

[458]  T. Shuin,et al.  Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer. , 1988, Cancer research.

[459]  P. Kiener,et al.  Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines. , 1988, Cancer research.

[460]  B. Angus,et al.  Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer. , 1988, British Journal of Cancer.

[461]  M. J. van de Vijver,et al.  Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. , 1988, The New England journal of medicine.

[462]  A. Schuurmans,et al.  Androgens and transforming growth factor β modulate the growth response to epidermal growth factor in human prostatic tumor cells (LNCaP) , 1988, Molecular and Cellular Endocrinology.

[463]  E. Tahara,et al.  Interaction between transforming growth factor-alpha and c-Ha-ras p21 in progression of human gastric carcinoma. , 1988, Pathology, research and practice.

[464]  I. Weinstein,et al.  Amplification of the EGF receptor and c‐myc genes in human esophageal cancers , 1988, International journal of cancer.

[465]  N. Hayward,et al.  A TaqI RFLP of the human TGFα gene is significantly associated with cutaneous malignant melanoma , 1988, International journal of cancer.

[466]  C. James,et al.  Clonal genomic alterations in glioma malignancy stages. , 1988, Cancer research.

[467]  B. Gusterson,et al.  c-erbB-2 expression in benign and malignant breast disease. , 1988, British Journal of Cancer.

[468]  M. Hollstein,et al.  Amplification of Epidermal Growth Factor Receptor Gene but Updated Version Citing Articles E-mail Alerts Amplification of Epidermal Growth Factor Receptor Gene but No Evidence of Ras Mutations in Primary Human Esophageal Cancers , 2013 .

[469]  R. Taetle,et al.  Effects of anti-epidermal growth factor (EGF) receptor antibodies and an anti-EGF receptor recombinant-ricin A chain immunoconjugate on growth of human cells. , 1988, Journal of the National Cancer Institute.

[470]  C. Osborne,et al.  Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis. , 1988, Cancer research.

[471]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[472]  G. Todaro,et al.  Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[473]  L. Murphy,et al.  Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins. , 1988, Cancer research.

[474]  M. Kashimata,et al.  Androgenic regulation of epidermal growth factor in the mouse ventral prostate. , 1988, Biochemistry international.

[475]  M. Resnick,et al.  A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer , 1988, Springer US.

[476]  T. Libermann,et al.  Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. , 1988, Cancer research.

[477]  Cori Bargmann,et al.  Oncogenic activation of the neu‐encoded receptor protein by point mutation and deletion. , 1988, The EMBO journal.

[478]  S. Bates,et al.  Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. , 1988, Molecular endocrinology.

[479]  A. Kaye,et al.  Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme. , 1988, Cancer research.

[480]  M. Brattain,et al.  Modulation of a high molecular weight form of transforming growth factor-alpha in human colon carcinoma cell lines. , 1988, Cancer letters.

[481]  B. Vogelstein,et al.  Gene Amplification in Malignant Human Gliomas: Clinical and Histopathologic Aspects , 1988, Journal of neuropathology and experimental neurology.

[482]  H. Yasumitsu,et al.  Transforming growth factors in urine from patients with primary brain tumors. , 1988, Journal of neurosurgery.

[483]  J. Bergh,et al.  Differential expression of platelet‐derived growth factor and transforming growth factor genes in small‐ and non‐small‐cell human lung carcinoma lines , 1988, International journal of cancer.

[484]  P. Humphrey,et al.  Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. , 1988, Cancer research.

[485]  M. Shibuya,et al.  Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors , 1988, Molecular and cellular biology.

[486]  J. Lillehaug,et al.  Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB. , 1988, British Journal of Cancer.

[487]  Y. Shiloh,et al.  Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues. , 1988, Cancer research.

[488]  M. Greene,et al.  Monoclonal antibodies reactive with distinct domains of the neu oncogene-encoded p185 molecule exert synergistic anti-tumor effects in vivo. , 1988, Oncogene.

[489]  A. Ochiai,et al.  Effect of human epidermal growth factor on cell growth and its receptor in human gastric carcinoma cell lines. , 1988, Japanese journal of clinical oncology.

[490]  G. Bepler,et al.  Epidermal growth factor receptor expression in human lung cancer cell lines. , 1988, Cancer research.

[491]  Phase I Trial of Cisplatin and Razoxane (ICRF‐ 159) (NSC #119875) in Advanced Squamous Cell Carcinoma of the Cervix A Gynecologic Oncology Group Pilot Study , 1988, American journal of clinical oncology.

[492]  J. Perheentupa,et al.  Urinary epidermal growth factor concentrations in various human malignancies. , 1988, British Journal of Cancer.

[493]  A. Gottlieb,et al.  Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes , 1988, The Journal of experimental medicine.

[494]  F. Taggi.  SAFETY HELMET LAW IN ITALY , 1988, The Lancet.

[495]  E. Šloncová,et al.  Analysis of epidermal growth factor and epidermal growth factor receptor expression in human renal carcinoma cell cultures. , 1988, Folia biologica.

[496]  A. Harris,et al.  Epidermal growth factor receptors in human breast cancer. , 1988, Cancer treatment and research.

[497]  L. Ghosh,et al.  Epidermal growth factor in the normal and neoplastic kidney and bladder. , 1988, The Journal of urology.

[498]  G. Unsgaard,et al.  Amplification of the epidermal growth factor receptor gene in biopsy specimens from human intracranial tumours. , 1988, British journal of neurosurgery.

[499]  Edwin Silverberg,et al.  Cancer statistics, 1988 , 1988, CA: a cancer journal for clinicians.

[500]  J. Miller,et al.  Epidermal growth factor binding in intracranial neoplasms: preliminary biochemical and clinicopathological findings. , 1988, British journal of neurosurgery.

[501]  C. Eaton,et al.  Growth Factor Receptors and Oncogene Expression in Prostate Cells , 1988, American journal of clinical oncology.

[502]  R. Greig,et al.  Growth factors as novel therapeutic targets in neoplastic disease. , 1988, Cancer surveys.

[503]  J. K. Kristensen,et al.  Epidermal growth factor in urine from patients with urinary bladder tumors. , 1988, European urology.

[504]  Atsushi Ochiai,et al.  Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. , 1988, Cancer research.

[505]  L. Nanney,et al.  Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. , 1987, The New England journal of medicine.

[506]  J. Marvaldi,et al.  Simultaneous production of IGF‐I and EGF competing growth factors by HT‐29 human colon cancer line , 1987, International journal of cancer.

[507]  M. Korc,et al.  Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[508]  E. Messing,et al.  Epidermal growth factor--interactions with normal and malignant urothelium: in vivo and in situ studies. , 1987, The Journal of urology.

[509]  D. Neal,et al.  Evaluation of epidermal growth factor receptors in bladder tumours. , 1987, British Journal of Cancer.

[510]  B. Vogelstein,et al.  Clonal analysis of human colorectal tumors. , 1987, Science.

[511]  A. Ullrich,et al.  Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[512]  K. Kinzler,et al.  Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[513]  R. Coffey,et al.  Transforming Growth Factor α and β Expression in Human Colon Cancer Lines: Implications for an Autocrine Model , 1987 .

[514]  B. Vonderhaar.  Local effects of EGF, α‐TGF, and EGF‐like growth factors on lobuloalveolar development of the mouse mammary gland in vivo , 1987 .

[515]  M. Berger,et al.  Expression of the c‐erbB‐2 protein in normal and transformed cells , 1987, International journal of cancer.

[516]  M. Berger,et al.  Epidermal growth factor receptors in lung tumours , 1987, The Journal of pathology.

[517]  C R King,et al.  erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. , 1987, Science.

[518]  A. Eisbruch,et al.  Analysis of the epidermal growth factor receptor gene in fresh human head and neck tumors. , 1987, Cancer research.

[519]  J. Farndon,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER , 1987, The Lancet.

[520]  A. Quaroni,et al.  Activated H-ras transforms rat intestinal epithelial cells with expression of α-TGF☆ , 1987 .

[521]  I. Pastan,et al.  Molecular evidence for the lack of epidermal growth factor receptor gene expression in small cell lung carcinoma cells. , 1987, Cancer research.

[522]  G. Gibson,et al.  Epidermal growth factor receptors in non-small cell lung cancer. , 1987, British Journal of Cancer.

[523]  E. Gelmann,et al.  Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. , 1987, Molecular endocrinology.

[524]  J. Tsai,et al.  Elevation of Transforming Growth Factor α and Its Relationship to the Epidermal Growth Factor and α-Fetoprotein Levels in Patients with Hepatocellular Carcinoma , 1987 .

[525]  D. Goeddel,et al.  Synthesis of Messenger RNAs for Transforming Growth Factors α and β and the Epidermal Growth Factor Receptor by Human Tumors , 1987 .

[526]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[527]  Harold L. Moses,et al.  Production and auto-induction of transforming growth factor-α in human keratinocytes , 1987, Nature.

[528]  Shu-sen Lin,et al.  Expression of epidermal growth factor receptors in human lung tumors , 1986, Cancer.

[529]  P. Hasleton,et al.  Expression of epidermal growth factor receptor (EGF-R) in human lung tumours. , 1986, British Journal of Cancer.

[530]  G. Bauer,et al.  Characterization of growth factors in human ovarian carcinomas. , 1986, Cancer research.

[531]  J. Yokota,et al.  AMPLIFICATION OF c-erbB-2 ONCOGENE IN HUMAN ADENOCARCINOMAS IN VIVO , 1986, The Lancet.

[532]  H. Moses,et al.  Growth factors and cancer. , 1986, Cancer research.

[533]  D. Salomon,et al.  Partial purification of transforming growth factors from human milk. , 1986, Cancer research.

[534]  M. Waterfield,et al.  Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas. , 1986, Cancer research.

[535]  P. Seeburg,et al.  Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. , 1985, Science.

[536]  B. Vonderhaar,et al.  Epidermal growth factor stimulates the growth of A431 tumors in athymic mice. , 1985, Cancer letters.

[537]  I. Pastan,et al.  Hyperproduction and gene amplification of the epidermal growth factor receptor in squamous cell carcinomas. , 1985, Japanese journal of cancer research : Gann.

[538]  T. Hunter.  Oncogenes and growth control , 1985 .

[539]  M. Bennett,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURS , 1985, The Lancet.

[540]  A. Walker,et al.  Epidemiology of brain tumors , 1985, Neurology.

[541]  James Scott,et al.  Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues , 1985, Nature.

[542]  Hermona Soreq,et al.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin , 1985, Nature.

[543]  D. Salomon,et al.  Presence of transforming growth factors in human breast cancer cells. , 1984, Cancer research.

[544]  J. Wittliff,et al.  Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. , 1984, Cancer research.

[545]  G. Schultz,et al.  Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. , 1984, Cancer research.

[546]  P. Seeburg,et al.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells , 1984, Nature.

[547]  M. Rosser,et al.  Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture. , 1984, Cancer research.

[548]  C. Muir,et al.  Estimates of the worldwide frequency of twelve major cancers. , 1984, Bulletin of the World Health Organization.

[549]  Y. Taketani,et al.  Biological action of epidermal growth factor and its functional receptors in normal mammary epithelial cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[550]  Y. Imai,et al.  Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture. , 1982, Cancer research.

[551]  C. Osborne,et al.  Epidermal growth factor stimulation of human breast cancer cells in culture. , 1980, Cancer research.

[552]  G. Burnstock,et al.  Guinea pig prostate is a rich source of nerve growth factor , 1979, Nature.

[553]  A. Harris.  Letter: Vitamin-C-induced hyperoxaluria. , 1976, Lancet.

[554]  S. Cohen,et al.  Epidermal growth factor: identification of a new hormone in human urine. , 1975, Science.

[555]  Martin Bf.  Cell replacement and differentiation in transitional epithelium: a histological and autoradiographic study of the guinea-pig bladder and ureter. , 1972 .

[556]  J. Soga,et al.  Pathologic analysis of carcinoids Histologic re evaluation of 62 cases , 1971, Cancer.

[557]  A. Monneron,et al.  Persistance de la synthèse de RNA extranucléolaires dans le foie de rats traités par la lasiocarpine. étude par autoradiographie a haute résolution , 1970 .

[558]  H. Third.  Hæmolytic Disease of the New-Born , 1958, Nature.